BrightSpring Health Services Inc. (BTSG) stock surged 5% in pre-market trading on Thursday, following the company's impressive fourth quarter and full-year 2024 financial results, as well as an increased guidance for fiscal 2025.
For the fourth quarter ended December 31, 2024, BrightSpring reported a 28.6% year-over-year increase in net revenue to $3.05 billion, beating analysts' expectations of $3.01 billion. The company's adjusted earnings per share of $0.22 met the consensus estimate, marking a significant improvement from $0.08 in the prior-year quarter.
BrightSpring's solid performance extended to the full year, with net revenue growing 27.6% to $11.27 billion and adjusted EBITDA rising 9.3% to $588 million compared to 2023. Excluding a one-time payment in 2023, adjusted EBITDA growth stood at an impressive 15.9%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。